Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Return on Assets (2016 - 2023)

Historic Return on Assets for Aptevo Therapeutics (APVO) over the last 8 years, with Q3 2023 value amounting to 0.02%.

  • Aptevo Therapeutics' Return on Assets changed 0.0% to 0.02% in Q3 2023 from the same period last year, while for Sep 2023 it was 0.02%, marking a year-over-year change of 0.0%. This contributed to the annual value of 0.02% for FY2022, which is 100.0% up from last year.
  • Per Aptevo Therapeutics' latest filing, its Return on Assets stood at 0.02% for Q3 2023, which was down 0.0% from 0.02% recorded in Q2 2023.
  • In the past 5 years, Aptevo Therapeutics' Return on Assets registered a high of 0.03% during Q4 2022, and its lowest value of 0.33% during Q2 2019.
  • Over the past 5 years, Aptevo Therapeutics' median Return on Assets value was 0.01% (recorded in 2021), while the average stood at 0.08%.
  • In the last 5 years, Aptevo Therapeutics' Return on Assets plummeted by -9200bps in 2019 and then surged by 3400bps in 2020.
  • Over the past 5 years, Aptevo Therapeutics' Return on Assets (Quarter) stood at 0.3% in 2019, then skyrocketed by 53bps to 0.14% in 2020, then soared by 111bps to 0.02% in 2021, then surged by 95bps to 0.03% in 2022, then crashed by -40bps to 0.02% in 2023.
  • Its Return on Assets was 0.02% in Q3 2023, compared to 0.02% in Q2 2023 and 0.02% in Q1 2023.